Latest Chemotherapy regimens Stories
By Eric Eyre For years, cancer patients have complained about the memory loss and attention problems they experience while undergoing chemotherapy.
By HELEN PUTTICK HEALTH CORRESPONDENT DRUGS to help battle cancer were approved for use by the NHS in Scotland yesterday.
Aveo Pharmaceuticals has started another Phase Ib clinical study for its lead product candidate, the triple VEGF receptor inhibitor AV-951.
A Japanese-led study suggests an experimental combination of chemotherapy agents might be a good alternative to standard lung cancer treatment.
SEATTLE, Aug. 5 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company") (Nasdaq: CTIC; MTA) t announced that Craig W. Philips has assumed his role as CTI's new President, and will concentrate on managing the company's drug development and commercial operations.
BETHLEHEM, Pa., June 23 /PRNewswire/ -- A new blood test may make it easier for oncologists to accurately measure and personalize 5-fluorouracil (5-FU) dosing for patients undergoing continuous infusion chemotherapy regimens.
Researchers from the Indiana University School of Medicine and the Purdue School of Science at Indiana University-Purdue University Indianapolis have created the first three-dimensional image of how a well-established chemotherapy agent targets and binds to DNA.
ORLANDO, Fla., Dec. 9 /PRNewswire/ -- Chemotherapy, the most common type of treatment for cancer patients, can cause troublesome side effects, such as nausea and vomiting, hair loss, fatigue, and life-threatening toxicities.
LOS ANGELES (Reuters) - The breast cancer drug Herceptin, shown recently to improve survival in women with early-stage breast cancer, carries with it a risk of heart damage, but a chemotherapy regimen can limit the danger, researchers said on Thursday.
New treatment advances for patients with follicular lymphoma, previously considered an incurable cancer, have reduced deaths in the first four years by 70 percent. A newly published study recommends that doctors carefully choose their patients' initial therapies because there are significant differences in overall survival rates, according to researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center.
- The act of sweetening by admixture of some saccharine substance.